Trials / Completed
CompletedNCT06812013
Impact of Idiopathic Scoliosis on Balance and Footprint Symmetry in Adolescents
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (actual)
- Sponsor
- Al-Zaytoonah University of Jordan · Academic / Other
- Sex
- All
- Age
- 10 Years – 18 Years
- Healthy volunteers
- Accepted
Summary
Adolescent idiopathic scoliosis (AIS) is the most prevalent form of scoliosis that affects children after the age of 10 years and is considered a critical developmental stage of the musculoskeletal system of the child. AIS causes deviations in the CNS, leading to asymmetry of motor activity and, consequently, an incorrect position of the spine. The progressive deformation of the spine leads to increased asymmetry in body functions. This elevated asymmetry is understood by the nervous system as a norm, which causes children to cease to sense the correct body position that may affect both static and dynamic balance and the foot pressure symmetry of the child, which was not investigated in such cases in any previous studies till now.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | assessment of foot print and balance | For static and dynamic balance assessment, Biodex Medical Systems Inc., Shirley, New York, USA (serial n.: 13020193) was used. The device consists of a circular foot platform that permits tilting in all directions, height-adjustable support rails, height adjustable display screen, and a printer. Balance assessment by the Biodex system is a valid and reliable objective measurement. For assessment of foot print symmetry Tekscan HR walkway Mat™ pressure measurement system, Tekscan Inc. USA will be use. It is made up of a digital mat inserted into a wooden walkway, sensors (4 senses/cm2) embedded in the mat, and a computer running the Tekscan Software (version 7) for data extrapolation. |
Timeline
- Start date
- 2025-02-10
- Primary completion
- 2025-05-05
- Completion
- 2025-05-08
- First posted
- 2025-02-06
- Last updated
- 2025-05-09
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06812013. Inclusion in this directory is not an endorsement.